ATE530564T1 - Peptid-komplement-konjugate - Google Patents
Peptid-komplement-konjugateInfo
- Publication number
- ATE530564T1 ATE530564T1 AT08716417T AT08716417T ATE530564T1 AT E530564 T1 ATE530564 T1 AT E530564T1 AT 08716417 T AT08716417 T AT 08716417T AT 08716417 T AT08716417 T AT 08716417T AT E530564 T1 ATE530564 T1 AT E530564T1
- Authority
- AT
- Austria
- Prior art keywords
- conjugates
- peptide
- peptide complement
- complement conjugates
- complement
- Prior art date
Links
- 230000000295 complement effect Effects 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/472—Complement proteins, e.g. anaphylatoxin, C3a, C5a
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus human T-cell leukaemia-lymphoma virus
- C07K14/155—Lentiviridae, e.g. human immunodeficiency virus [HIV], visna-maedi virus or equine infectious anaemia virus
- C07K14/16—HIV-1 ; HIV-2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- AIDS & HIV (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07005096 | 2007-03-13 | ||
PCT/EP2008/001908 WO2008110332A1 (en) | 2007-03-13 | 2008-03-11 | Peptide-complement conjugates |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE530564T1 true ATE530564T1 (de) | 2011-11-15 |
Family
ID=37998311
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT08716417T ATE530564T1 (de) | 2007-03-13 | 2008-03-11 | Peptid-komplement-konjugate |
Country Status (17)
Country | Link |
---|---|
US (1) | US20090143288A1 (de) |
EP (1) | EP2118125B1 (de) |
JP (1) | JP5081931B2 (de) |
KR (1) | KR101182951B1 (de) |
CN (1) | CN101616929B (de) |
AR (1) | AR065688A1 (de) |
AT (1) | ATE530564T1 (de) |
AU (1) | AU2008226051B2 (de) |
BR (1) | BRPI0808732A2 (de) |
CA (1) | CA2679647A1 (de) |
CL (1) | CL2008000707A1 (de) |
ES (1) | ES2374962T3 (de) |
IL (1) | IL199718A0 (de) |
MX (1) | MX2009009370A (de) |
PE (1) | PE20090163A1 (de) |
TW (1) | TW200902544A (de) |
WO (1) | WO2008110332A1 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0913385D0 (en) | 2009-07-31 | 2009-09-16 | Medical House The Plc | Improved autoinjector |
JP5757639B2 (ja) * | 2010-09-14 | 2015-07-29 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | セルピンフィンガー融合ポリペプチド |
CA2907046C (en) * | 2013-03-15 | 2021-04-20 | Atyr Pharma, Inc. | Histidyl-trna synthetase-fc conjugates |
US11958887B2 (en) | 2017-05-17 | 2024-04-16 | The General Hospital Corporation | Gene therapy for tuberous sclerosis |
Family Cites Families (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8928874D0 (en) | 1989-12-21 | 1990-02-28 | Celltech Ltd | Humanised antibodies |
CA2096222C (en) | 1990-11-13 | 1998-12-29 | Stephen D. Lupton | Bifunctional selectable fusion genes |
ES2101834T3 (es) * | 1990-11-27 | 1997-07-16 | Biogen Inc | Anticuerpos anti-cd4 que bloquean sincitios inducidos por vih. |
US6136310A (en) * | 1991-07-25 | 2000-10-24 | Idec Pharmaceuticals Corporation | Recombinant anti-CD4 antibodies for human therapy |
EP1266965B1 (de) | 1991-07-25 | 2006-05-24 | Biogen Idec Inc. | Rekombinante Antikörper zur humanen Therapie |
DE69326069T2 (de) * | 1992-07-20 | 2000-03-23 | Univ Durham | Zusammensetzungen die die hiv replikation inhibieren |
EP0804590A1 (de) | 1993-05-21 | 1997-11-05 | Targeted Genetics Corporation | Bifunktionelle selektierbare fusionsgene auf dem cytosin-deaminase (cd) gen beruhend |
US6479055B1 (en) | 1993-06-07 | 2002-11-12 | Trimeris, Inc. | Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission |
US6017536A (en) * | 1993-06-07 | 2000-01-25 | Trimeris, Inc. | Simian immunodeficiency virus peptides with antifusogenic and antiviral activities |
US5464933A (en) | 1993-06-07 | 1995-11-07 | Duke University | Synthetic peptide inhibitors of HIV transmission |
WO1996036359A1 (en) | 1995-05-18 | 1996-11-21 | Ortho Pharmaceutical Corporation | Induction of immunological tolerance by the use of non-depleting anti-cd4 antibodies |
US6743594B1 (en) * | 1995-06-06 | 2004-06-01 | Human Genome Sciences, Inc. | Methods of screening using human G-protein chemokine receptor HDGNR10 (CCR5) |
NZ311319A (en) * | 1995-06-07 | 2000-01-28 | Trimeris Inc | The treatment of HIV and other viral infections using the peptide DP-178 or DP-107 in combination therapy |
EP0975749A2 (de) * | 1996-05-28 | 2000-02-02 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Cc chemokine receptor 5, antikörper dazu, transgene tieren |
CA2256306C (en) | 1996-06-03 | 2011-03-29 | United Biomedical, Inc. | Antibodies against a complex of cd4 and a chemokine receptor domain, and their use against hiv infections |
US6020159A (en) | 1996-09-24 | 2000-02-01 | Smithkline Beecham Corporation | 3-dehydroquinate synthase |
US6528625B1 (en) * | 1996-10-28 | 2003-03-04 | Millennium Pharmaceuticals, Inc. | Anti-CCR5 antibodies and kits comprising same |
US5888809A (en) * | 1997-05-01 | 1999-03-30 | Icos Corporation | Hamster EF-1α transcriptional regulatory DNA |
US6020495A (en) * | 1997-12-08 | 2000-02-01 | Pharm-Eco Laboratories, Inc. | Stereoselective method for synthesizing dolaphenine |
US6258782B1 (en) * | 1998-05-20 | 2001-07-10 | Trimeris, Inc. | Hybrid polypeptides with enhanced pharmacokinetic properties |
US6656906B1 (en) * | 1998-05-20 | 2003-12-02 | Trimeris, Inc. | Hybrid polypeptides with enhanced pharmacokinetic properties |
US6610834B1 (en) * | 1998-11-18 | 2003-08-26 | Peter I. Lobo | Human IgM antibodies to chemokine receptors |
US20030099645A1 (en) * | 2000-10-10 | 2003-05-29 | Lobo Peter Isaac | Naturally occuring IgM antibodies that bind to membrane receptors on lymphocytes |
DK1144006T3 (da) | 1998-12-16 | 2007-11-26 | Progenics Pharm Inc | Synergistisk inhibering af HIV-1-fusion og -binding, præparater og antistoffer dertil |
JP2002540771A (ja) | 1999-03-11 | 2002-12-03 | マック,マティーアス | 抗体構築物およびケモカイン構築物ならびに自己免疫疾患の治療におけるそれらの使用 |
ES2334106T3 (es) | 1999-05-17 | 2010-03-05 | Conjuchem Biotechnologies Inc. | Inhibidores peptidos de fusion de larga vida contra infecciones virales. |
AU2841101A (en) * | 1999-12-08 | 2001-06-18 | Novartis Ag | Methods and compositions useful for inhibiting ccr5-dependent infection of cellsby hiv-1 |
AU2265701A (en) | 1999-12-16 | 2001-06-25 | Tanox, Inc. | Anti-hiv-1 conjugates for treatment of hiv disease |
US6692745B2 (en) * | 2000-01-28 | 2004-02-17 | Arogenics Pharmaceuticals, Inc. | Compositions and methods for inhibition of HIV-1 infection |
CN1227265C (zh) | 2000-02-09 | 2005-11-16 | 人类基因组科学公司 | 抗ccr5的抗体 |
US20040043033A1 (en) * | 2000-05-01 | 2004-03-04 | Green Lorrence H. | Method and vaccine for the prevention of AIDS |
US7138119B2 (en) * | 2000-09-15 | 2006-11-21 | Progenics Pharmaceuticals, Inc. | Compositions and methods for inhibition of HIV-1 infection |
US20030165988A1 (en) * | 2002-02-08 | 2003-09-04 | Shaobing Hua | High throughput generation of human monoclonal antibody against peptide fragments derived from membrane proteins |
US7005503B2 (en) * | 2002-02-08 | 2006-02-28 | Genetastix Corporation | Human monoclonal antibody against coreceptors for human immunodeficiency virus |
EP1207202A1 (de) | 2000-11-16 | 2002-05-22 | Mölling, Karin, Inst. für med. Virologie der Uni. Zürich | Nukleinsäuremoleküle, welche für ein Protein kodieren, das mit dem Chemokinrezeptor oder anderen Mitgliedern der Chemokinrezeptorfamilie interagiert |
US20020147147A1 (en) * | 2000-11-16 | 2002-10-10 | Karin Molling | Nucleic acid molecules encoding a protein interacting with the chemokine receptor CCR5 or other chemokine receptor family members |
US7175988B2 (en) * | 2001-02-09 | 2007-02-13 | Human Genome Sciences, Inc. | Human G-protein Chemokine Receptor (CCR5) HDGNR10 |
US20030003440A1 (en) * | 2001-03-14 | 2003-01-02 | Lucia Lopalco | Novel CCR5 epitope and antibodies against it |
US7060273B2 (en) * | 2001-04-06 | 2006-06-13 | Progenics Pharmaceuticals, Inc. | Methods for inhibiting HIV-1 infection |
US20020146415A1 (en) | 2001-04-06 | 2002-10-10 | Olson William C. | Methods for inhibiting HIV-1 infection |
JP4267444B2 (ja) * | 2001-06-15 | 2009-05-27 | エフ.ホフマン−ラ ロシュ アーゲー | Gp41フラグメントのアセチル化 |
WO2003033666A2 (en) | 2001-10-16 | 2003-04-24 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Broadly cross-reactive neutralizing antibodies against human immunodeficiency virus selected by env-cd4-co-receptor complexes |
AU2003209059A1 (en) | 2002-02-08 | 2003-09-02 | Genetastix Corporation | Human monoclonal antibodies against membrane proteins |
US7122185B2 (en) * | 2002-02-22 | 2006-10-17 | Progenics Pharmaceuticals, Inc. | Anti-CCR5 antibody |
IL163655A0 (en) | 2002-02-22 | 2005-12-18 | Protein Design Labs Inc | Anti-ccr5 antibody |
EP1460088A1 (de) * | 2003-03-21 | 2004-09-22 | Biotest AG | Humanisierter Antikörper gegen CD4 mit immunsuppressiven Merkmalen |
JP2007517522A (ja) * | 2004-01-07 | 2007-07-05 | トリメリス,インコーポレーテッド | HIVgp41HR2由来の合成ペプチド、およびヒト免疫不全ウイルスの伝播を阻止する治療におけるその使用 |
TW200720289A (en) | 2005-04-01 | 2007-06-01 | Hoffmann La Roche | Antibodies against CCR5 and uses thereof |
-
2008
- 2008-03-10 TW TW097108371A patent/TW200902544A/zh unknown
- 2008-03-10 US US12/075,183 patent/US20090143288A1/en not_active Abandoned
- 2008-03-10 CL CL200800707A patent/CL2008000707A1/es unknown
- 2008-03-11 MX MX2009009370A patent/MX2009009370A/es active IP Right Grant
- 2008-03-11 AT AT08716417T patent/ATE530564T1/de active
- 2008-03-11 EP EP08716417A patent/EP2118125B1/de not_active Not-in-force
- 2008-03-11 ES ES08716417T patent/ES2374962T3/es active Active
- 2008-03-11 WO PCT/EP2008/001908 patent/WO2008110332A1/en active Application Filing
- 2008-03-11 CA CA002679647A patent/CA2679647A1/en not_active Abandoned
- 2008-03-11 BR BRPI0808732-6A patent/BRPI0808732A2/pt not_active IP Right Cessation
- 2008-03-11 AU AU2008226051A patent/AU2008226051B2/en not_active Ceased
- 2008-03-11 JP JP2009552135A patent/JP5081931B2/ja not_active Expired - Fee Related
- 2008-03-11 AR ARP080100996A patent/AR065688A1/es unknown
- 2008-03-11 KR KR1020097018750A patent/KR101182951B1/ko not_active IP Right Cessation
- 2008-03-11 CN CN2008800052530A patent/CN101616929B/zh not_active Expired - Fee Related
- 2008-03-12 PE PE2008000470A patent/PE20090163A1/es not_active Application Discontinuation
-
2009
- 2009-07-07 IL IL199718A patent/IL199718A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
IL199718A0 (en) | 2010-04-15 |
KR20090115867A (ko) | 2009-11-09 |
AR065688A1 (es) | 2009-06-24 |
MX2009009370A (es) | 2009-09-14 |
PE20090163A1 (es) | 2009-03-12 |
AU2008226051A1 (en) | 2008-09-18 |
CL2008000707A1 (es) | 2008-09-22 |
TW200902544A (en) | 2009-01-16 |
AU2008226051B2 (en) | 2012-05-24 |
JP2010520868A (ja) | 2010-06-17 |
JP5081931B2 (ja) | 2012-11-28 |
KR101182951B1 (ko) | 2012-09-13 |
CA2679647A1 (en) | 2008-09-18 |
EP2118125A1 (de) | 2009-11-18 |
BRPI0808732A2 (pt) | 2014-08-12 |
CN101616929B (zh) | 2013-08-14 |
EP2118125B1 (de) | 2011-10-26 |
US20090143288A1 (en) | 2009-06-04 |
WO2008110332A1 (en) | 2008-09-18 |
CN101616929A (zh) | 2009-12-30 |
ES2374962T3 (es) | 2012-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3118220T3 (da) | Protein | |
BRPI0821573A2 (pt) | benzofuropirimidonas | |
ATE501136T1 (de) | Imidazopyridinone | |
ATE514696T1 (de) | Diphenyl-dihydro-imidazopyridinone | |
DE112008003636A5 (de) | Mehrzuggruppierer | |
DK2132326T3 (da) | Fremgangsmåder | |
BRPI0814971A2 (pt) | Proteína | |
DE502007001207D1 (de) | Elektrosaugkopf | |
BRPI0811451A2 (pt) | Exopolissacarídeo | |
BRPI0814519A2 (pt) | Organopolissiloxano | |
BRPI0812840A2 (pt) | 2-imidazolinas | |
BRPI0815547A2 (pt) | Depsipeptídeos cícliocos | |
AT505058A3 (de) | Türschliesssystem | |
BRPI0812994A2 (pt) | Microbiocidas | |
FR22C1045I2 (fr) | Conjugués protéine-polymère | |
DE602008003159D1 (de) | Schalter | |
DE112008001216A5 (de) | Magnetronplasmaanlage | |
DE502008001694D1 (de) | Mitfahrhubwagen | |
DE112008003094A5 (de) | Geomatte | |
DE112008003196A5 (de) | Handpipettiergerät | |
DE112008002200A5 (de) | Sperrsynchronisiervorrichtung | |
DE602008000326D1 (de) | Schalter | |
CU20090155A7 (es) | Macrolidos | |
ATE530564T1 (de) | Peptid-komplement-konjugate | |
DE102007038931A8 (de) | Fadenlagennähwirkstoffe |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 2118125 Country of ref document: EP |